Skip to content

Stereotactic Radiosurgery (SRS)

RADIATION20 trials

Sponsors

Duke University, Stanford University, Samsung Medical Center, Steven Burton, Sidney Kimmel Cancer Center at Thomas Jefferson University

Conditions

Adult Solid TumorBrain MetastasesBreast CancerCancer of Brain and Nervous SystemGlioblastomaGlioblastoma MultiformeHR+ Metastatic Breast CancerIntracranial Aneurysm

Phase 1

Phase 1-2 of Temozolomide and Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
CompletedNCT01120639
Stanford UniversityCancer of Brain and Nervous System, Glioblastoma, Glioblastoma Multiforme
Start: 2010-04-30End: 2020-11-15Updated: 2021-08-06
Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma
CompletedNCT01703507
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityRecurrent Melanoma, Stage IV Melanoma, Tumors Metastatic to Brain
Start: 2012-11-09End: 2018-04-11Updated: 2025-05-16
SRS (Stereotactic Radiosurgery) Plus Ipilimumab
TerminatedNCT01950195
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNewly Diagnosed Melanoma Metastases in the Brain and Spine
Start: 2013-09-30Updated: 2016-11-15
Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma
CompletedNCT04474353
Stanford UniversityGlioblastoma, Newly Diagnosed Glioblastoma
Start: 2021-05-21End: 2025-09-02Updated: 2025-12-26
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
RecruitingNCT04923542
H. Lee Moffitt Cancer Center and Research InstituteBrain Metastases, HR+ Metastatic Breast Cancer
Start: 2021-11-30End: 2026-12-01Target: 31Updated: 2026-02-06
A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain
Active, not recruitingNCT06132945
Memorial Sloan Kettering Cancer CenterBrain Metastases, Metastatic Renal Cell Carcinoma
Start: 2023-11-10End: 2027-11-30Updated: 2025-11-14

Phase 2

Phase 3

Unknown Phase

Radiosurgery and Avastin for Recurrent Malignant Gliomas
CompletedNCT01017250
Duke UniversityMalignant Glioma
Start: 2009-12-31End: 2012-02-29Updated: 2014-02-28
Radiosurgery for Patients Recurrent Oligometastatic Disease
CompletedNCT01345552
Steven BurtonRecurrent Oligometastatic Disease
Start: 2011-06-28End: 2022-10-11Updated: 2023-05-19
Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain Metastases
WithdrawnNCT01731704
University of California, San FranciscoBrain Metastases
Start: 2012-12-31End: 2018-12-31Updated: 2017-03-14
A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)
TerminatedNCT01821443
University of California, San FranciscoBrain Metastases
Start: 2012-12-31End: 2015-10-22Updated: 2018-01-23
Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence
CompletedNCT03303365
Juergen DebusAdult Solid Tumor, Brain Metastases
Start: 2018-02-01End: 2021-06-01Updated: 2022-11-03
Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain
TerminatedNCT03488472
Drexell Hunter BoggsBrain Metastases, Small Cell Lung Cancer
Start: 2019-08-09End: 2022-02-15Updated: 2023-05-06
Radiosurgery With or Without Whole Brain Radiation for Multiple Metastases
RecruitingNCT03775330
Sunnybrook Health Sciences CentreBrain Metastases
Start: 2020-10-20End: 2025-12-31Target: 126Updated: 2025-05-18
Brain Low-risk Aneurysm Stereotactic Radiosurgical Trial
Not yet recruitingNCT06047951
Dr David MathieuIntracranial Aneurysm
Start: 2025-06-30End: 2030-06-30Target: 40Updated: 2025-02-14

Related Papers